Issue 1/2011
Content (18 Articles)
Assessment of MMP-9, TIMP-1, and COX-2 in normal tissue and in advanced symptomatic and asymptomatic carotid plaques
Liz Andréa V Baroncini, Lia S Nakao, Simone G Ramos, Antonio Pazin Filho, Luiz Otávio Murta Jr, Max Ingberman, Cristiane Tefé-Silva, Dalton B Précoma
Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism
Jawed Fareed, Cafer Adiguzel, Indermohan Thethi
Venous thromboembolism prophylaxis guideline implementation is improved by nurse directed feedback and audit
Harry Gibbs, John Fletcher, Peter Blombery, Renea Collins, David Wheatley
Life-threatening aortic thrombosis in a trauma patient homozygous for factor V Leiden mutation: Case report
Iraklis Tsangaris, Georgios Tsaknis, Argirios Tsantes, Petros Kopterides, Apostolos Armaganidis
EMILIN2 (Elastin microfibril interface located protein), potential modifier of thrombosis
Qila Sa, Jane L Hoover-Plow
Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis
Jaume Figueras, Jasone Monasterio, Enric Domingo, Beatriz Meneses, Elsa Nieto, Josefa Cortadellas, David Garcia-Dorado
Development of a microplate coagulation assay for Factor V in human plasma
Derek Tilley, Irina Levit, John A Samis
Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective
Raul Altman, Hector O Vidal
Upper limb artery segmental occlusions due to chronic use of ergotamine combined with itraconazole, treated by thrombolysis
Edoardo Cervi, Stefano Bonardelli, Giuseppe Battaglia, Federico Gheza, Roberto Maffeis, Franco Nodari, Roberto Maroldi, Stefano M Giulini
Using highly variable warfarin dosing to identify patients at risk for adverse events
Lyndonna Marrast, Mary Evans, Al Ozonoff, Lori E Henault, Adam J Rose
Sequential thrombosis and bleeding in a woman with a prolonged activated partial thromboplastin time
Akpan Spencer, Michael I Pearce, Paul RJ Ames
Risk of venous thromboembolism and benefits of prophylaxis use in hospitalized medically ill US patients up to 180 days post-hospital discharge
Li Wang, Nishan Sengupta, Onur Baser
Adherence to local guidelines for venous thromboprophylaxis: a cross-sectional study of medical inpatients in Argentina
Agustín Languasco, Mariana Galante, Josefina Marín, Cristina Soler, Cristián Lopez Saubidet, Matías Milberg
The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients
Abdulaziz Aldawood, Yaseen Arabi, Abdulrahman Aljumah, Alawi Alsaeedi, Asgar Rishu, Hasan Aldorzi, Saad Alqahtani, Mohammad Alsultan, Afaf Felemban
An unexpected case of venous and pulmonary thrombo-embolism in a patient treated with thalidomide for refractory erythema nodosum leprosum: a case report
Riyaaz Ahamed, Wijesiriwardena Bandula, Ratnayake Chamara
Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement
George Dranitsaris, Valentina Jelincic, Yoonhee Choe
The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
Alf-Aage R Pettersen, Harald Arnesen, Trine B Opstad, Ingebjorg Seljeflot